This Solicitation opportunity from Department Of Defense was posted on July 13, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

EMOLLIENT LOTION

Closed

SPE2DP-26-T-4010Federal

Submission Closed07/16/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Antibodies Elution Kit Supplier (NSN 6550-01-346-4878)This subcontract involves the supply of finished Antibodies Elution Kits, identified by NSN 6550-01-346-4878, for prime contractors serving the Department of Defense Medical Supply Chain. The required kits must contain concentrated wash, eluting, and buffering solutions designed for the rapid acid elution of antibodies from red blood cells. All deliverables must strictly adhere to FDA regulations, MIL-STD-2073-1E packaging requirements, and Medical Marking Standard No. 1. The scope of work requires the delivery of two complete kits to Keesler AFB, with each kit maintaining a minimum shelf-life of one month. This procurement falls under NAICS code 325412 and is managed through the DLA Troop Support Medical Supply Chain.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Gabapentin Capsules SupplyThis subcontract involves the supply of FDA-regulated Gabapentin Capsules (100 MG) to support prime contractors on Department of Defense medical supply chain projects. The scope of work requires the manufacture or procurement of ten bottles of capsules that strictly adhere to FDA regulations and USP Controlled Room Temperature standards of 25 degrees Celsius. To maintain a non-extendable shelf life of 36 months, all products must be handled in FDA-approved facilities and transported using climate-monitored shipping containers. The contract is managed by the Medical Supply Chain Pharm FSA and requires full compliance with the Buy American Act. Performance will take place in Washington, DC, under NAICS code 325412. Interested parties must note the response deadline of November 16, 2026, to ensure all regulatory and delivery specifications are met for this pharmaceutical procurement.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Hypoallergenic Soft Tissue Massage CreamThis subcontract involves the supply of non-greasy, hypoallergenic soft tissue massage cream for prime contractors supporting the Medical Supply Chain Pharm FSA under the Department of Defense. The supplier must provide products that strictly adhere to FDA regulations and meet the specifications of NSN 6508017007944. To ensure product integrity, items must be stored in heated environments maintained at 40 degrees Fahrenheit or above. The contract requires the delivery of six 15 oz containers to Fort Polk, Louisiana, on a FOB Destination basis. All packaging and labeling must comply with MIL-STD-2073-1E, MIL-STD-129, and Medical Marking Standard No. 1. This procurement falls under NAICS code 325412, with a response deadline set for November 16, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Povidone-Iodine Cleansing Solution ManufacturerThis subcontract involves the manufacture and supply of Povidone-Iodine Cleansing Solution for prime contractors supporting MEDICAL SUPPLY CHAIN PHARM FSA projects under the Department of Defense. The solution must be produced according to USP standards, featuring a 7.5% active ingredient and a shelf life of 36 months. The product is to be delivered in one-gallon bottles, which must include SDS and Hazardous Communication Standard labels in accordance with 29 C.F.R. 1910.1200. Additionally, the manufacturer must ensure full compliance with the Buy American Act. Performance for this contract is designated for FPO 96665.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

POVIDONE-IODINE CLEANS

Solicitation # SPE2DP-27-T-0271

This procurement involves the supply of Povidone-Iodine Cleansing Solution, USP, with a 7.5% active ingredient for external use. The product must be delivered in one-gallon bottles with a total shelf life of 36 months, ensuring at least 31 months remain upon delivery to the first government activity. Storage must be maintained at 25 degrees Fahrenheit, with permitted excursions between 15 and 30 degrees Celsius. The contract specifies delivery to the USS Harpers Ferry and USS Carter Hall, with a required delivery timeline of 20 days and FOB Destination terms. The contractor must adhere to strict packaging and marking standards, utilizing Medical Marking Standard No. 1 and MIL-STD-129. Hazardous materials must be packaged according to TQ requirement IP025 and FED-STD-313, and suppliers are required to submit Safety Data Sheets and Hazardous Communication Standard labels per 29 C.F.R. 1910.1200 prior to award. The contract is governed by various FAR and DFARS clauses, including requirements for safeguarding covered defense information, compliance with the Buy American Act, and the prohibition of covered defense telecommunications equipment. All payment requests must be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0270

Solicitation SPE2DP-27-T-0270 is a Small Business Set-Aside procurement issued by the Defense Logistics Agency for the acquisition of 10 bottles of Gabapentin Capsules, 100 MG, in quantities of 100 per bottle. This FDA-regulated drug must be stored at 25C with permitted excursions between 15C and 30C per USP Controlled Room Temperature standards. The item has a non-extendable shelf life of 36 months. Delivery is required FOB Destination to a medical detachment in Washington, DC, with a required delivery date of November 12, 2026. The contract mandates commercial packaging and packing, requiring each unit to be in a sealed container to prevent damage, with shipping containers ensuring safe delivery. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and payment. The procurement incorporates various FAR and DFARS clauses, including the Buy American Act, NIST SP 800-171 cybersecurity requirements, and strict prohibitions on covered defense telecommunications equipment.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

6505--Nitroglycerin Patches

Solicitation # 36E79727R0010

The Department of Veterans Affairs National Acquisition Center is initiating an unrestricted procurement for Nitroglycerin Patches under solicitation 36E79727R0010. This contract will serve the VA, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award will be granted to a single responsible offeror capable of providing an uninterrupted source of supply for a one-year base period followed by four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. The procurement covers four strengths of Nitroglycerin patches (0.1 mg, 0.2 mg, 0.4 mg, and 0.6 mg), with estimated annual usage ranging from 2,213 to 10,044 boxes. All patches must be supplied in boxes of 30 and must feature barcoding on both the individual patch and the outside box. Strict labeling requirements apply: the contractor must provide a unique NDC number, and their label must be the only one on the product, without being affixed over another label. Additionally, the labels must allow VA labels to adhere securely over them. This solicitation will be issued in commercial item format per FAR Part 12, with a tentative issuance date of December 1, 2026, and a closing date of December 15, 2026.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

6505--AREDS2 ophthalmic multivitamins

Solicitation # 36E79727R0009

The Department of Veterans Affairs National Acquisition Center is initiating an unrestricted procurement under solicitation 36E79727R0009 for MULTIVIT/OPHTH AREDS2/LUTEIN/ZEAXANTHIN capsules or tablets. This contract is designed to provide an uninterrupted source of supply for the Department of Veterans Affairs, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The estimated annual requirement is 829,230 bottles of 120-count packaging, with distribution managed through the respective Pharmaceutical Prime Vendor Programs of the VA and DoD. The contract will be awarded to a single responsible offeror for a base period of one year, followed by four pre-priced one-year option periods. The procurement follows FAR Part 12 commercial item format under NAICS code 325412. Strict labeling requirements apply: the contractor must provide a unique NDC number, and their label must be the only one on the product, with a prohibition against affixing labels over existing ones. The solicitation is expected to be issued electronically via SAM.gov on approximately December 23, 2026, with a tentative closing date of January 13, 2027.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

Supply of Calcium Trisodium Pentetate (Ca-DTPA) Sterile InjectablesThis subcontract involves the supply of Calcium Trisodium Pentetate (Ca-DTPA) sterile injectables to prime contractors supporting medical countermeasure projects for the Government of Canada's Department of National Defence. The scope of work requires the manufacture and delivery of 750 to 1,250 sterile 5.0 mL ampoules, each containing between 1,000 mg and 1,055 mg of the active ingredient for intravenous injection. To be eligible, the provider must operate sterile pharmaceutical manufacturing facilities and hold valid marketing authorization from Health Canada, the US FDA, the EMA, or an EU member state. The contract is categorized under NAICS code 325412, with performance taking place in Canada. Responses to this opportunity are due by November 25, 2026.

Department of National Defence

POSTED

DEADLINE

Calcium Trisodium Pentetate (Ca-DTPA) ampoules

Solicitation # W6369-27-A062

The Department of National Defence, through the Strategic Medical Countermeasures Program on behalf of the Canadian Forces Health Services Group, is seeking the supply of Calcium Trisodium Pentetate (Ca-DTPA) ampoules to treat Canadian Armed Forces personnel exposed to radioactive contamination involving transuranic elements. The required product must be a sterile solution for intravenous injection containing 1,000 mg to 1,055 mg of active ingredient in a 5 mL ampoule, with a minimum shelf-life of 36 months from the date of manufacture. To ensure consistency with existing stockpiles, the product must adhere to specific packaging and labelling requirements and hold valid marketing authorization from Health Canada, the FDA, the EMA, or an EU member state. The procurement is being conducted via an Advance Contract Award Notice, with Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG identified as the sole known supplier capable of meeting the technical and clinical requirements. The contract is anticipated to run from the award date until March 31, 2031, with an estimated total value of 47,500 CAD. The firm requirement consists of 750 ampoules delivered in three annual increments of 250, starting no later than March 1, 2027, and ending by March 1, 2029. Additionally, the contract includes an option for up to 500 more ampoules exercisable throughout the contract period. This procurement is subject to the Canadian Free Trade Agreement and is not subject to set-asides or the Procurement Strategy for Indigenous Business.

Department of National Defence

POSTED

DEADLINE

Pharmaceutical Grade Salicylic Acid SupplyThis subcontract involves the supply of high-purity, pharmaceutical-grade salicylic acid to prime contractors supporting Department of Defense projects under the DLA Troop Support Medical Supply Chain. The scope of work encompasses the chemical synthesis and purification of the acid to ensure it meets strict pharmaceutical standards for topical medical applications. All deliverables must be accompanied by SDS documentation and hold USP or equivalent pharmaceutical grade certifications. The project is categorized under NAICS code 325412 and is managed by the Medical Supply Chain MD Surg FSF. Performance of the contract is designated for FPO 09564. Interested parties should note the response deadline of November 16, 2026, for this bulk supply requirement.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

BISMUTH SUBSALICYLATE

Solicitation # SPE2DP-27-T-0266

This solicitation, issued by the Defense Logistics Agency (DLA) under number SPE2DP-27-T-0266, is a small business set-aside for the procurement of 55 packages of over-the-counter, sugar-free Bismuth Subsalicylate tablets. Each tablet must contain 262 mg of Bismuth Subsalicylate and 140 mg of Calcium, with each unit of issue consisting of 48 individually sealed tablets. The product has a total shelf life of 36 months, and a minimum of 31 months must remain at the time of receipt by the first government activity. To maintain product integrity, the supplies must be protected from excessive heat exceeding 104 degrees Fahrenheit or 40 degrees Celsius. The contract specifies that packaging and packing must be commercial, with each unit in a sealed container and shipped in suitable commercial exterior containers to ensure safe delivery. Marking and labeling must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and preservation must follow MIL-STD-2073-1E. Delivery is required FOB Destination to the DC ARNG MED DET in Washington, DC, with a delivery lead time of 20 days. Inspection and acceptance will occur at the destination. The procurement incorporates various FAR and DFARS clauses, including requirements for safeguarding covered defense information, NIST SP 800-171 assessment, and the Buy American Act. Invoicing must be processed electronically through the Wide Area Workflow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 6 days

AI Contract Overview

The contract is for the procurement of 500 bottles of Emollient Lotion, each containing 240 mL (8 fl oz) in a non-sterile, homogeneous oil-in-water or water-in-oil emulsion formulation with a dispenser cap. The product must have a pH between 5.0 and 8.1 and contain a minimum of water, a suitable oil, an emulsifier, and a preservative; additional ingredients such as stabilizers, thickeners, emollients, surfactants, humectants, coloring agents, and fragrances may be included in sufficient quantities. The lotion must exhibit a viscosity between 10,000 and 20,000 CPS at 25°C when tested using a Brookfield viscometer Model LVT with spindle no. 13 at 6 RPM. It must be stored at controlled room temperature and packaged in accordance with the latest edition of Medical Marking Standard No. 1 and MIL-STD-129, with unit of issue as a bottle (BT) and quantity per unit pack designated as 1. Packaging must comply with RP001 DLA Packaging Requirements for Procurement, and if classified as hazardous under FED-STD-313, must adhere to TQ requirement IP025; otherwise, commercial packaging under ASTM D3951 applies, though DLA technical requirements take precedence. The item is regulated by the FDA and requires referral through EBS for product specialist confirmation prior to award. The contract line item calls for delivery of 500 bottles to the USS GEORGE WASHINGTON CVN 73, FPO AP 96607, with FOB destination terms and a 20-day delivery window from the date of government direction. The original required delivery date is July 8, 2026, with no variance permitted in quantity. Inspection and acceptance occur at destination, with WAWF required for all invoicing and receiving reports. The contract incorporates multiple federal acquisition regulations including those on trafficking in persons, employment eligibility, sustainable products, hazardous material identification, cybersecurity safeguards, and safeguarding defense information. Contractors must provide their UEI and CAGE code, comply with all DLA Master List technical and quality requirements, and submit Safety Data Sheets for any hazardous materials prior to award. The solicitation was issued on July 13, 2026, and closed for responses on July 1

General Info

Procure 500 units of Emollient Lotion NSN 6508-01-019-7181 via DLA by July 13, 2026, open to all qualified contractors.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

UNIT 100148 BOX 1, FPO, AP, 96607, USA

Set-Aside

NONE

Documents

rfq

High

AI Contract Breakdown

Uniform Contract Format

Timeline

1 update

PhaseClosed

PostedJul 6

Solicitation

Notice updatedJul 13

Response deadline changed from Jul 13, 2026 to Jul 16, 2026. NAICS code added: 325412. The notice description changed. The point of contact changed.

Response DeadlineJul 16

Deadline has passed

Submission Closed

07/16/2026, 05:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUSA

Organization / AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUSA

Contacts

Parris Sandlin

contact@example.gov

+1 (555) 000-0000

Full Description

EMOLLIENT LOTION
EMOLLIENT LOTION
.
HOMOGENEOUS, NON-STERILE, BOTTLE W/DISPENSER CAP,
240 ML (8 FL OZ); PH RANGE BETWEEN 5.0 AND 8.1.
.
OIL IN WATER OR WATER IN OIL EMULSION. SHALL CONTAIN A
MINIMUM OF THE FOLLOWING INGREDIENTS IN SUFFICIENT QUANTITIES<(>,<)>
WATER<(>,<)> A SUITABLE OIL<(>,<)> EMULSIFIER AND A PRESERVATIVE; OTHER
INGREDIENTS SUCH AS EMULSION STABILIZERS<(>,<)> THICKENING AGENTS<(>,<)>
EMOLLIENTS<(>,<)> SURFACTANTS<(>,<)> HUMECTANTS<(>,<)> COLORING AGENTS
AND FRAGRANCES MAY BE ADDED IN SUFFICIENT QUANTITIES.
.
STORE AT CONTROLLED ROOM TEMPERATURE. HAS VISCOSITY
OF 10,000 CPS TO 20,000 CPS AT 25 DEG C PORM 2 DEG C USING A BROOKFIELD
VISCOMETER MODEL LVT (OR QUIVALENT) W/SPINDLE NO. 13 AND SPEED 6 RPM
.
UNIT OF ISSUE: BOTTLE (BT) OF 8 FL OZ
.
SHALL BE MARKED IAW THE LATEST EDITION OF MEDICAL MARKING STANDARD NO. 1
HTTPS://WWW.DLA.MIL/LOGISTICS-OPERATIONS/PACKAGING/
.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. ..
AMERISOURCEBERGEN DRUG CORP 1XUY5 P/N NDC00096-0722-08
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-4010
SECTION B
PR: 7017380652 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017380652 0001 BT 500.000
NSN/MATERIAL:6508010197181
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
R21412
USS GEORGE WASHINGTON CVN 73
UNIT 100148 BOX 1
FPO AP 96607
US
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
R21412
USS GEORGE WASHINGTON CVN 73
DLA VENDORS: USE VSM FOR
US
RDD 777 SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
M/F: (TCN) R214126183P184
RDD: 777
PROJ: EP5 TP 2
SUPP ADD: YNMED SIG: A
SPE2DP-26-T-4010
SECTION B
PR: 7017380652 PRLI: 0001 CONT’D
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A41 DIST: 9B ADV: 2A FC: L7
Need Ship Date:00/00/0000 Original Required Delivery Date:07/08/2026
SPE2DP-26-T-4010 NSN/Part Number: 6508-01-019-7181 Quantity: 500 BT Purchase Request: 7017380652QTY: 500 Delivery: 20 days ADO